Literature DB >> 18617167

Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies.

Pranav Kumar1, Ashutosh Kumar, Shyam Sundar Verma, Namrata Dwivedi, Nasib Singh, Mohammad Imran Siddiqi, Rama Pati Tripathi, Anuradha Dube, Neeloo Singh.   

Abstract

Pteridine reductase 1 (PTR1, EC 1.5.1.33) is a NADPH dependent short-chain reductase (SDR) responsible for the salvage of pterins in the protozoan parasite Leishmania. This enzyme acts as a metabolic bypass for drugs targeting dihydrofolate reductase, therefore, for successful antifolate chemotherapy to be developed against Leishmania, it must target both enzyme activities. Based on homology model drawn on recombinant pteridine reductase isolated from a clinical isolate of L. donovani, we carried out molecular modeling and docking studies with two compounds of dihydrofolate reductase specificity showing promising antileishmanial activity in vitro. Both the inhibitors appeared to fit well in the active pocket revealing the tight binding of the carboxylic acid ethyl ester group of pyridine moiety to pteridine reductase and identify the important interactions necessary to assist the structure based development of novel pteridine reductase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617167     DOI: 10.1016/j.exppara.2008.05.005

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis.

Authors:  Jaspreet Kaur; Pranav Kumar; Sargam Tyagi; Richa Pathak; Sanjay Batra; Prashant Singh; Neeloo Singh
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

2.  Leishmania donovani pteridine reductase 1: comparative protein modeling and protein-ligand interaction studies of the leishmanicidal constituents isolated from the fruits of Piper longum.

Authors:  Shakti Sahi; Parul Tewatia; Sabari Ghosal
Journal:  J Mol Model       Date:  2012-07-03       Impact factor: 1.810

3.  Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-/structure-based virtual screening approach.

Authors:  Chonny Herrera-Acevedo; Mayara Dos Santos Maia; Élida Batista Vieira Sousa Cavalcanti; Ericsson Coy-Barrera; Luciana Scotti; Marcus Tullius Scotti
Journal:  Mol Divers       Date:  2020-09-09       Impact factor: 2.943

4.  Exploring actinomycetes natural products to identify potential multi-target inhibitors against Leishmania donovani.

Authors:  Satyendra Singh; Vijay Kumar Prajapati
Journal:  3 Biotech       Date:  2022-08-20       Impact factor: 2.893

5.  An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1.

Authors:  Neeloo Singh; Jaspreet Kaur; Pranav Kumar; Swati Gupta; Nasib Singh; Angana Ghosal; Avijit Dutta; Ashutosh Kumar; Ramapati Tripathi; Mohammad Imran Siddiqi; Chitra Mandal; Anuradha Dube
Journal:  Parasitol Res       Date:  2009-07-21       Impact factor: 2.289

6.  Genomic organization of leishmania species.

Authors:  B Kazemi
Journal:  Iran J Parasitol       Date:  2011-08       Impact factor: 1.012

Review 7.  Chalcone Derivatives: Promising Starting Points for Drug Design.

Authors:  Marcelo N Gomes; Eugene N Muratov; Maristela Pereira; Josana C Peixoto; Lucimar P Rosseto; Pedro V L Cravo; Carolina H Andrade; Bruno J Neves
Journal:  Molecules       Date:  2017-07-25       Impact factor: 4.411

8.  Synthesis and Biological Evaluation of Tetrahydropyrimidine and Dihydropyridine Derivatives Against Leishmania Major.

Authors:  Behnaz Jeddi; Sedigheh Saberi; J Carlos Menéndez; Saghi Sepehri
Journal:  Acta Parasitol       Date:  2021-07-19       Impact factor: 1.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.